Longer-term follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE

被引:0
|
作者
Marantz, J. [1 ]
Gold, R. [2 ]
Giovannoni, G. [3 ]
Phillips, J. T. [4 ]
Fox, R. J. [5 ]
Zhang, A. [1 ]
机构
[1] Biogen Inc, Cambridge, MA 02142 USA
[2] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[3] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[4] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[5] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P564
引用
收藏
页码:263 / 263
页数:1
相关论文
共 50 条
  • [21] Six-year follow-up of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM and ENDORSE
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D.
    Zhang, R.
    Yang, M.
    Rana, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 264 - 265
  • [22] Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Meltzer, Leslie
    Kurukulasuriya, Nuwan C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 57 - 66
  • [23] Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE
    Yousry, T.
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    MacManus, D.
    Sheikh, S.
    Zhang, R.
    Yang, M.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 156 - 156
  • [24] Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE
    Kurukulasuriya, N. C.
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 93 - 93
  • [25] Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years' Follow-up of DEFINE, CONFIRM, and ENDORSE (vol 13, pg 1, 2020)
    Gold, R.
    Arnold, D. L.
    Bar-Or, A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [26] Clinical efficacy of delayed-release dimethyl fumarate in Hispanic patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hernandez, L.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E306
  • [27] Clinical efficacy of delayed-release dimethyl fumarate in Asian patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hochman, S.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E307
  • [28] Clinical efficacy of delayed-release dimethyl fumarate in relapsing-remitting MS (RRMS) patients with highly active disease: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Gold, R.
    Zhang, A.
    Yang, M.
    Zhang, R.
    Kurukulasuriya, N. C.
    Fox, R. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 458 - 458
  • [29] Clinical efficacy of delayed-release dimethyl fumarate in relapsing-remitting MS (RRMS) patients with highly active disease: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Gold, R.
    Zhang, A.
    Yang, M.
    Zhang, R.
    Kurukulasuriya, N. C.
    Fox, R. J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S303 - S304
  • [30] Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis Using a Composite Measure of Disability: Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Phillips, J. Theodore
    Bar-Or, Amit
    Gold, Ralf
    Giovannoni, Gavin
    Fox, Robert
    Potts, James
    Soman, Teesta
    Marantz, Jing
    NEUROLOGY, 2016, 86